Developer docs
API playgroundTry for free, no card

Search company profiles

Lateral

Full company profile

uuid002mo61

Namestring
Lateral
Legal namestring
Lateral Partners Ltd.
Websiteurl
lateral.london
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Lateral (Lateral Partners Ltd.) is a UK-based property investment, development, and asset management firm founded in 2020 and headquartered at 28 Fitzroy Square, London. The company specialises in science and technology real estate, acquiring, repositioning, developing, and managing assets for life sciences, biotech, medtech, AI, quantum, and advanced manufacturing occupiers across London's Knowledge Quarter (King's Cross, Bloomsbury, Shad Thames), the Whitechapel life sciences corridor, Cambridge, and Oxford. Co-founded by Rob Beacroft, Robert Crawley, and Nicholas Beacroft, the company operates a founder-led team of fewer than ten professionals covering development, science design, planning, construction, and capital structuring, supported by a wider ecosystem of institutional and public-sector partners.

The company's core offering comprises three service lines — property investment, property development, and asset management — underpinned by a proprietary research methodology called the Cluster Integration Model, which maps institutional ecosystems to identify sectors where co-location with healthcare and university anchors creates the greatest innovation impact. Active projects include the 620,000+ sq ft Camley Street regeneration with Camden Council and Ballymore (400 new homes, 50% affordable), the 115,000 sq ft Cavell Street life sciences development in Whitechapel with Barts Health NHS Trust and Queen Mary University of London, an 85,000 sq ft Cambridge innovation campus at Radio House and St Andrew's House, and a 16,000 sq ft repositioning of the Grade II-listed Conran Building in joint venture with Amazon Capital. The team reports a cumulative track record of 4M sq ft of life science space delivered, 17M sq ft of planning secured, £3bn contract sum delivered, £2bn in acquisitions GAV, and 125 schemes designed.

Lateral's business model combines project-level joint venture equity (with Amazon Capital, Ballymore, Devonshire Group), competitive public procurement (Camden Council), anchor partnerships with NHS trusts and universities, direct pre-letting to occupiers (e.g., Nuclera at One Vision Park Cambridge), and selective asset disposals to institutional investors (e.g., Trinity House sold to Breakthrough Properties for £41 million in 2022). Revenue is generated through development management fees, asset management fees, capital appreciation, and rental income. Lateral does not publicly disclose company-level financials and is privately held with no disclosed institutional equity investment in the parent entity.

Short descriptiontext

Lateral is a UK property investment, development, and asset management firm specialising in science and technology real estate across London, Cambridge, and Oxford, serving institutional investors, councils, universities, and life sciences occupiers through ecosystem-led development and joint venture partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
science property investment, life sciences real estate, property development services, asset management services, innovation district development
Industry1 code
PRIMARYFSAEAJAD
Land Brokerage (Raw Land & Development Sites)
NAICS code1 code
  • Land Subdivision23721
SIC code2 codes
  • Land Subdividers & Developers (No Cemeteries)6552
  • Real Estate Dealers (For Their Own Account)6532
Product category
Science and Technology Real Estate Investment and Development
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Property Development and Investment
TypeOne Time License
Description

Lateral originates, funds, acquires, develops and manages property assets. Revenue generated through capital appreciation, development profits, and rental income from science and technology properties. Projects span investment, development, and asset management across the UK.

lateral.london
2Asset Management Fees
TypeProfessional Services
Description

Ongoing asset management services for partners and occupiers, maximizing asset value through proactive relationships and community-focused management.

lateral.london
3Development Management
TypeProfessional Services
Description

Development management services providing project delivery expertise, planning, design oversight, and construction management for science and technology developments.

lateral.london
4Site Disposal and Value Unlocking
TypeTransaction Fee
Description

Strategic repositioning of underutilised assets followed by sale to institutional investors. Trinity House was sold to Breakthrough Properties for £41 million after Lateral created demand-led business plan.

lateral.london
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Lateral is a UK property investment, development and asset management company focused on science and technology real estate. The firm originates, funds, acquires, develops and manages lab, tech and life sciences properties across London, Cambridge and Oxford, using its proprietary Cluster Integration Model to map ecosystems (research institutions, hospitals, talent) and identify demand-led development opportunities. Core services cover investment structuring, full-cycle development, and ongoing asset management for partners and occupiers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 4M sq ft of life science space delivered
+4 more records
Product and service3 records
1Property Investment Services
CategoryInvestment services
2Property Development Services
CategoryDevelopment services
3Asset Management Services
CategoryAsset management services
Scale indicator17 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-21
Description

Brookfield advancing wider masterplan for over 1m sq ft at ARC Oxford following Trinity House proof-of-concept that demonstrated Oxford Business Park's potential for life sciences.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Collaboration on Ignite Your Imagination STEM program, delivering careers events for Year 5 students from diverse backgrounds across North & East London.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Collaboration on STEM engagement initiatives creating pathways into life sciences careers for local communities.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Careers & Social Mobility team collaboration on Ignite Your Imagination STEM program and Whitechapel Life Sciences Cluster Social Impact Strategy.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Collaboration on Whitechapel Life Sciences Cluster Social Impact Strategy - pioneering 15-year framework for tackling health and economic inequalities in Tower Hamlets.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Collaboration on Whitechapel Life Sciences Cluster Social Impact Strategy framework for inclusive innovation.

7Camden Council
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Public-private partnership through competitive procurement for Camley Street redevelopment in King's Cross. Lateral and Ballymore selected as preferred partner to deliver 620,000+ sq ft mixed-use innovation hub with 400 new homes (50% affordable), science and tech space, and community infrastructure.

lateral.london
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Joint venture partnership with Lateral and Camden Council for Camley Street regeneration. Ballymore contributes regeneration track record alongside Lateral's science and technology expertise.

Strategic tierMinorTypeOthersAnnounced on2022-02-07
Description

Trinity House sold to Breakthrough Properties for £41 million, enabling next phase of development in Oxford science and technology cluster.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Anchor partnership for Whitechapel life sciences cluster. Cavell Street development aligned with Royal London Hospital's therapeutic priorities, ensuring research and innovation directly benefit patient care and community outcomes.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Partner for Cavell Street development leveraging QMB ecosystem to bring clinicians, researchers, and companies together in Whitechapel life sciences hub.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-03-07
Description

Partnership to develop Trinity House at Oxford Business Park. Lateral created demand-led business plan proving case for science-led development at office-led business park.

13Amazon Capital
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-22
Description

Joint venture with Amazon Capital to acquire the Conran Building in Shad Thames, London. Combined capital and expertise for repositioning design-led heritage asset.

lateral.london
Strategic tierMinorTypeOthersAnnounced on2021-01-01
Description

Breakthrough Properties delivered 170,000 sq ft new-build Trinity House scheme following Lateral's proof-of-concept.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Joint venture between Tishman Speyer and Bellco Capital focused on life sciences real estate globally and the acquirer of Lateral's Trinity House — competing for and partnering on the same UK life sciences schemes.

TypeBroad incumbent
Description

Global institutional real estate investor with a growing life sciences platform and Oxford presence; comparable as an incumbent capital allocator that may compete for or partner on UK life sciences schemes in Lateral's orbit.

TypeEmerging player
Description

UK REIT expanding into life sciences and innovation-led real estate via adaptive reuse, mirroring Lateral's strategy of converting non-lab buildings into science and tech space across central London.

TypeBroad incumbent
Description

Established UK commercial developer with comparable London-centric, large-format regeneration and mixed-use delivery track record; competes for similar public and institutional mandates.

TypeBroad incumbent
Description

UK developer behind the King's Cross regeneration including substantial science, tech, and life sciences space — directly adjacent to Lateral's Camley Street scheme and a benchmark comparable for London innovation district delivery.

TypeDirect peer
Description

UK-based developer and operator with a major life sciences and innovation property portfolio (including Bruntwood SciTech), competing for the same cluster opportunities in Manchester, Birmingham, and other UK innovation districts as Lateral.

TypeBroad incumbent
Description

Central London office specialist with adjacent expertise in adaptive reuse and tech/scientific occupier fit-out; comparable for science and tech office conversions in London's Knowledge Quarter and similar clusters.

TypeDirect peer
Description

European life sciences real estate specialist operating science and tech campuses across the UK and continental Europe — directly comparable to Lateral's cluster-led, ecosystem-driven approach to science property development and asset management.

TypeBroad incumbent
Description

Blackstone-owned life sciences REIT operating at significantly larger scale globally; a major incumbent in lab space that competes with Lateral for institutional capital and occupier relationships in life sciences clusters.

TypeBroad incumbent
Description

Major UK regeneration developer and Lateral's JV partner on Camley Street; comparable for large-scale mixed-use regeneration in London with overlap on the science and innovation component of schemes.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lateral

Science and Technology Real Estate Investment and Developmentlateral.london

Lateral is a UK property investment, development, and asset management firm specialising in science and technology real estate across London, Cambridge, and Oxford, serving institutional investors, councils, universities, and life sciences occupiers through ecosystem-led development and joint venture partnerships.

What Lateral does

Lateral (Lateral Partners Ltd.) is a UK-based property investment, development, and asset management firm founded in 2020 and headquartered at 28 Fitzroy Square, London. The company specialises in science and technology real estate, acquiring, repositioning, developing, and managing assets for life sciences, biotech, medtech, AI, quantum, and advanced manufacturing occupiers across London's Knowledge Quarter (King's Cross, Bloomsbury, Shad Thames), the Whitechapel life sciences corridor, Cambridge, and Oxford. Co-founded by Rob Beacroft, Robert Crawley, and Nicholas Beacroft, the company operates a founder-led team of fewer than ten professionals covering development, science design, planning, construction, and capital structuring, supported by a wider ecosystem of institutional and public-sector partners.

The company's core offering comprises three service lines — property investment, property development, and asset management — underpinned by a proprietary research methodology called the Cluster Integration Model, which maps institutional ecosystems to identify sectors where co-location with healthcare and university anchors creates the greatest innovation impact. Active projects include the 620,000+ sq ft Camley Street regeneration with Camden Council and Ballymore (400 new homes, 50% affordable), the 115,000 sq ft Cavell Street life sciences development in Whitechapel with Barts Health NHS Trust and Queen Mary University of London, an 85,000 sq ft Cambridge innovation campus at Radio House and St Andrew's House, and a 16,000 sq ft repositioning of the Grade II-listed Conran Building in joint venture with Amazon Capital. The team reports a cumulative track record of 4M sq ft of life science space delivered, 17M sq ft of planning secured, £3bn contract sum delivered, £2bn in acquisitions GAV, and 125 schemes designed.

Lateral's business model combines project-level joint venture equity (with Amazon Capital, Ballymore, Devonshire Group), competitive public procurement (Camden Council), anchor partnerships with NHS trusts and universities, direct pre-letting to occupiers (e.g., Nuclera at One Vision Park Cambridge), and selective asset disposals to institutional investors (e.g., Trinity House sold to Breakthrough Properties for £41 million in 2022). Revenue is generated through development management fees, asset management fees, capital appreciation, and rental income. Lateral does not publicly disclose company-level financials and is privately held with no disclosed institutional equity investment in the parent entity.

Lateral firmographics

Firmographics
Name
Lateral
Legal name
Lateral Partners Ltd.
Website
https://lateral.london
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
Lateral is a UK property investment, development, and asset management firm specialising in science and technology real estate across London, Cambridge, and Oxford, serving institutional investors, councils, universities, and life sciences occupiers through ecosystem-led development and joint venture partnerships.
Ownership category
akta.pro rank

Lateral industry classification

Industry
Product category
Science and Technology Real Estate Investment and Development
NAICS
Land Subdivision (23721)
SIC
Land Subdividers & Developers (No Cemeteries) (6552), Real Estate Dealers (For Their Own Account) (6532)
akta.pro industry
PRIMARYFSAEAJAD
Land Brokerage (Raw Land & Development Sites)

Keywords

  • Science property investment
  • Life sciences real estate
  • Property development services
  • Asset management services
  • Innovation district development

Where Lateral is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Lateral business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Property Development and Investment: Lateral originates, funds, acquires, develops and manages property assets. Revenue generated through capital appreciation, development profits, and rental income from science and technology properties. Projects span investment, development, and asset management across the UK.
  2. Asset Management Fees: Ongoing asset management services for partners and occupiers, maximizing asset value through proactive relationships and community-focused management.
  3. Development Management: Development management services providing project delivery expertise, planning, design oversight, and construction management for science and technology developments.
  4. Site Disposal and Value Unlocking: Strategic repositioning of underutilised assets followed by sale to institutional investors. Trinity House was sold to Breakthrough Properties for £41 million after Lateral created demand-led business plan.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Lateral product offering

Product offering

Core offering

Lateral is a UK property investment, development and asset management company focused on science and technology real estate. The firm originates, funds, acquires, develops and manages lab, tech and life sciences properties across London, Cambridge and Oxford, using its proprietary Cluster Integration Model to map ecosystems (research institutions, hospitals, talent) and identify demand-led development opportunities. Core services cover investment structuring, full-cycle development, and ongoing asset management for partners and occupiers.

Differentiator

Problem solved

Functional benefit

Products and services

  • Property Investment Services
  • Property Development Services
  • Asset Management Services

Quantifiable outcome

  • 4M sq ft of life science space delivered
  • +4 more outcomes

Companies that use Lateral

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Lateral technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Lateral partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered minor and core.

  • BrookfieldminorStrategic or Co-development Partner · 21 January 2025Brookfield advancing wider masterplan for over 1m sq ft at ARC Oxford following Trinity House proof-of-concept that demonstrated Oxford Business Park's potential for life sciences.
  • H.I.G. Realty PartnersminorStrategic or Co-development Partner · 1 January 2025Collaboration on Ignite Your Imagination STEM program, delivering careers events for Year 5 students from diverse backgrounds across North & East London.
  • LIFT ProgrammeminorStrategic or Co-development Partner · 1 January 2025Collaboration on STEM engagement initiatives creating pathways into life sciences careers for local communities.
  • Tower Hamlets CouncilminorStrategic or Co-development Partner · 1 January 2025Careers & Social Mobility team collaboration on Ignite Your Imagination STEM program and Whitechapel Life Sciences Cluster Social Impact Strategy.
  • Montagu EvansminorStrategic or Co-development Partner · 1 January 2025Collaboration on Whitechapel Life Sciences Cluster Social Impact Strategy - pioneering 15-year framework for tackling health and economic inequalities in Tower Hamlets.
  • AkouminorStrategic or Co-development Partner · 1 January 2025Collaboration on Whitechapel Life Sciences Cluster Social Impact Strategy framework for inclusive innovation.
  • Camden CouncilcoreStrategic or Co-development Partner · 1 January 2024Public-private partnership through competitive procurement for Camley Street redevelopment in King's Cross. Lateral and Ballymore selected as preferred partner to deliver 620,000+ sq ft mixed-use innovation hub with 400 new homes (50% affordable), science and tech space, and community infrastructure.
  • BallymorecoreStrategic or Co-development Partner · 1 January 2024Joint venture partnership with Lateral and Camden Council for Camley Street regeneration. Ballymore contributes regeneration track record alongside Lateral's science and technology expertise.
  • Breakthrough PropertiesminorOthers · 7 February 2022Trinity House sold to Breakthrough Properties for £41 million, enabling next phase of development in Oxford science and technology cluster.
  • Barts Health NHS TrustcoreStrategic or Co-development Partner · 1 January 2022Anchor partnership for Whitechapel life sciences cluster. Cavell Street development aligned with Royal London Hospital's therapeutic priorities, ensuring research and innovation directly benefit patient care and community outcomes.
  • Queen Mary University of LondoncoreStrategic or Co-development Partner · 1 January 2022Partner for Cavell Street development leveraging QMB ecosystem to bring clinicians, researchers, and companies together in Whitechapel life sciences hub.
  • Devonshire GroupcoreStrategic or Co-development Partner · 7 March 2021Partnership to develop Trinity House at Oxford Business Park. Lateral created demand-led business plan proving case for science-led development at office-led business park.
  • Amazon CapitalcoreStrategic or Co-development Partner · 22 January 2021Joint venture with Amazon Capital to acquire the Conran Building in Shad Thames, London. Combined capital and expertise for repositioning design-led heritage asset.
  • Breakthrough PropertiesminorOthers · 1 January 2021Breakthrough Properties delivered 170,000 sq ft new-build Trinity House scheme following Lateral's proof-of-concept.

Scale indicators17 records

Recent moves7 records

Expansion highlights6 records

Lateral competitors and assessment

Company assessment

Direct peers

  • Breakthrough Properties: Joint venture between Tishman Speyer and Bellco Capital focused on life sciences real estate globally and the acquirer of Lateral's Trinity House — competing for and partnering on the same UK life sciences schemes.
  • Bruntwood: UK-based developer and operator with a major life sciences and innovation property portfolio (including Bruntwood SciTech), competing for the same cluster opportunities in Manchester, Birmingham, and other UK innovation districts as Lateral.
  • Kadans Science Partner: European life sciences real estate specialist operating science and tech campuses across the UK and continental Europe — directly comparable to Lateral's cluster-led, ecosystem-driven approach to science property development and asset management.

Broad incumbents

  • Oxford Properties: Global institutional real estate investor with a growing life sciences platform and Oxford presence; comparable as an incumbent capital allocator that may compete for or partner on UK life sciences schemes in Lateral's orbit.
  • Stanhope: Established UK commercial developer with comparable London-centric, large-format regeneration and mixed-use delivery track record; competes for similar public and institutional mandates.
  • Argent: UK developer behind the King's Cross regeneration including substantial science, tech, and life sciences space — directly adjacent to Lateral's Camley Street scheme and a benchmark comparable for London innovation district delivery.
  • Derwent London: Central London office specialist with adjacent expertise in adaptive reuse and tech/scientific occupier fit-out; comparable for science and tech office conversions in London's Knowledge Quarter and similar clusters.
  • BioMed Realty: Blackstone-owned life sciences REIT operating at significantly larger scale globally; a major incumbent in lab space that competes with Lateral for institutional capital and occupier relationships in life sciences clusters.
  • Ballymore: Major UK regeneration developer and Lateral's JV partner on Camley Street; comparable for large-scale mixed-use regeneration in London with overlap on the science and innovation component of schemes.

Emerging players

  • Helical: UK REIT expanding into life sciences and innovation-led real estate via adaptive reuse, mirroring Lateral's strategy of converting non-lab buildings into science and tech space across central London.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Lateral social profiles

Digital presence

Lateral financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lateral leadership team

Management profile

Number of profiles

Profiles8 records

Lateral funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lateral M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lateral

What does Lateral do?

Lateral is a UK property investment, development and asset management company focused on science and technology real estate. The firm originates, funds, acquires, develops and manages lab, tech and life sciences properties across London, Cambridge and Oxford, using its proprietary Cluster Integration Model to map ecosystems (research institutions, hospitals, talent) and identify demand-led development opportunities. Core services cover investment structuring, full-cycle development, and ongoing asset management for partners and occupiers.

Is Lateral a public or private company?

Lateral is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Lateral founded?

Lateral was founded in 2020. It employs 1 to 10 people.

Where is Lateral based?

Lateral is headquartered in London, United Kingdom, in the Europe region.

How does Lateral make money?

Four revenue lines are on record. Property Development and Investment is the primary driver. The others are asset Management Fees, development Management and site Disposal and Value Unlocking.

Who are Lateral's main competitors?

Direct peers on record are Breakthrough Properties, Bruntwood and Kadans Science Partner. Broad incumbents are Oxford Properties, Stanhope, Argent, Derwent London, BioMed Realty and Ballymore. Helical is listed as an emerging player.

Does Lateral have an API?

No public API is recorded for Lateral.

What industry is Lateral in?

Lateral's product category is Science and Technology Real Estate Investment and Development. Its primary akta.pro industry code is FSAEAJAD, Land Brokerage (Raw Land & Development Sites). Its NAICS code is 23721 and its SIC code is 6552.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PharmiWeb.comThe Barts Life Sciences Cluster Launches in Whitechapel, East LondonThe Barts Life Sciences Cluster officially launched on 25 November 2025 in Whitechapel, East London, as a landmark partnership between Barts Health NHS Trust and private investors BGO, H.I.G. Capital, and Lateral, with planned investment exceeding £800m. The approximately 25-acre cluster aims to unite clinical excellence and commercial innovation, creating 5 million sq ft of clinical, research, and commercial space dedicated to MedTech, AI, digital health, and therapeutics around The Royal London Hospital. Supported by academic partner Queen Mary University of London and industry body ABHI, the initiative is expected to generate over £0.75bn in GVA and create thousands of new jobs, with Science Minister Lord Vallance framing it as central to the UK's ambitions to become Europe's leader in life sciences.PR NewswireH.I.G. Realty Announces Strategic Partnership with Queen Mary BioEnterprises Innovation Centre in LondonH.I.G. Capital has signed a strategic partnership with Queen Mary BioEnterprises Innovation Centre to develop 40,000 square feet of incubator space at its flagship innovation centre in Whitechapel, London. The project, developed in collaboration with Lateral and involving Barts Life Sciences, Barts Health NHS Trust, Queen Mary University of London, and the UK Department of Health & Social Care, aims to establish a world-class life sciences cluster in Whitechapel. The incubator will provide facilities for startups and spinouts, with the goal of creating jobs, fostering career pathways, and promoting education in life sciences and STEM sectors.PR NewswireH.I.G. Realty gaat strategisch partnerschap aan met Queen Mary BioEnterprises Innovation Centre in LondenH.I.G. Capital's real estate subsidiary H.I.G. Realty has entered into a strategic partnership with Queen Mary BioEnterprises Innovation Centre (QMB) to deliver 3,700 square meters of incubator space at its flagship innovation centre in Whitechapel, London. H.I.G. and its development partner Lateral will collaborate with Barts Life Sciences, Barts Health NHS Trust, Queen Mary University of London, and the UK Department of Health and Social Care to establish the Whitechapel Life Science Cluster. The new space aims to support digital startups and life science companies by providing high-quality facilities and shared services, creating long-term jobs and educational opportunities in the biopharmaceutical and STEM sectors.PR NewswireH.I.G. Realty Announces Strategic Partnership with Queen Mary BioEnterprises Innovation Centre in LondonH.I.G. Capital announced a strategic partnership with Queen Mary BioEnterprises Innovation Centre to develop 40,000 square feet of incubator space at its flagship innovation centre in Whitechapel, London. H.I.G. Realty and its development partner Lateral will collaborate with Barts Life Sciences, Barts Health NHS Trust, and Queen Mary University of London on this project, marking a significant milestone for the Whitechapel Life Science Cluster. The development aims to create a world-class life sciences cluster that will nurture startup companies, generate high-quality jobs, and promote education in life sciences and STEM sectors.